Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alina Y. Babenko"'
Publikováno v:
Ожирение и метаболизм, Vol 15, Iss 4, Pp 22-30 (2018)
Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1)
Externí odkaz:
https://doaj.org/article/f731a7ef47e14e0cb15c924df39aab22
Autor:
Anna A. Mosikian, Alina Y. Babenko, Yulia A. Sevastyanova, Roman V. Drai, Evgenij V. Shlyakhto
Publikováno v:
Сахарный диабет, Vol 21, Iss 5, Pp 333-343 (2018)
Background: Individualized treatment has already become a part of a routine clinical care. Many data on the effectiveness prediction of commercially available DPP-4 inhibitors had been published, but not on the effectiveness prediction of evogliptin.
Externí odkaz:
https://doaj.org/article/0cda49c2db13461287d49fbf760d288a
Autor:
Alina Y. Babenko, Anna A. Mosikian, Igor E. Makarenko, Victoriya V. Leusheva, Evgeny V. Shlyakhto
Publikováno v:
Сахарный диабет, Vol 21, Iss 4, Pp 241-254 (2018)
Background: Dipeptidyl-peptidase-4 inhibitors (iDPP-4) are pathogenically targeted drugs for diabetes mellitus type 2 (T2DM). Evogliptin is a new member of iDPP-4 class. The drug has the longest half-elimination period among the class, and its effica
Externí odkaz:
https://doaj.org/article/27831b07e20444e996454c54095fada3
Publikováno v:
Future Science OA, Vol 8, Iss 3 (2022)
Background: The effects of liraglutide on body weight and hemoglobin A1C (HbA1c) level vary greatly. The cost of this drug negatively affects treatment adherence. Aim: To reveal the baseline patient characteristics, associated with a better response
Externí odkaz:
https://doaj.org/article/0381052c0e684e96aa77752c9cf96234
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Endocrine Disorders
BMC Endocrine Disorders
BackgroundThyrotoxic atrial fibrillation (TAF) is a recognized significant complication of hyperthyroidism. Early identification of the individuals predisposed to TAF would improve thyrotoxic patients’ management. However, to our knowledge, an inst
Autor:
Ekaterina B. Luneva, Anastasia A. Vasileva, Elena V. Karelkina, Maria A. Boyarinova, Evgeny N. Mikhaylov, Anton V. Ryzhkov, Alina Y. Babenko, Alexandra O. Konradi, Olga M. Moiseeva
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 10; Pages: 2843
Cardiac fibrosis is the basis of structural and functional disorders in patients with diabetes mellitus (T2DM). A wide range of laboratory and instrumental methods is used for its prediction. The study aimed to identify simple predictors of cardiac f
Publikováno v:
Problems of Endocrinology. 66:104-112
BACKGROUND: Spontaneous recovery of the hypothalamic–pituitary–gonadal (HPG) axis after cessation of testosterone replacement therapy or after male contraception may take up to 24 months. There is insufficient data on the duration of recovery of
Autor:
Alina Y. Babenko, Mykola P. Lykhonosov
Publikováno v:
Problems of Endocrinology. 65:124-133
The purpose of this review is to assess the prevalence of AA steroid use, to identify the steroids that are used, and to present the negative effects of AA steroids on the human body while describing the mechanisms of their actions on the male reprod
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Lecture Notes in Computer Science ISBN: 9783030504229
ICCS (4)
ICCS (4)
Thyrotoxicosis (TT) is associated with an increase in both total and cardiovascular mortality. One of the main thyrotoxicosis complications is Atrial Fibrillation (AF). Right AF predictors help medical personal prescribe the select patients with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8ee1992a92781a9ae067c03e541c15d
https://doi.org/10.1007/978-3-030-50423-6_37
https://doi.org/10.1007/978-3-030-50423-6_37